Loss of acetylcholinesterase activity in human erythrocytes treated with cephalothin.
D000017:ABO Blood-Group System; D000110:Acetylcholinesterase / Q000097:blood*; D002462:Cell Membrane / Q000201:enzymology; D002509:Cephaloridine / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D002512:Cephalothin / Q000494:pharmacology*; D004912:Erythrocytes / Q000201:enzymology*; D006452:Hemoglobinometry; D006461:Hemolysis; D006801:Humans; D012204:Rh-Hr Blood-Group System
D000017:ABO Blood-Group System; D002511:Cephalosporins; D012204:Rh-Hr Blood-Group System; D000110:Acetylcholinesterase; D002509:Cephaloridine; D002512:Cephalothin